Specialty Research Peptides
L-Carnitine Supplier China: 400mg to 1200mg Guide
Research Use Only (RUO). Products and information are intended exclusively for qualified laboratory research. Not for human consumption, clinical treatment or diagnostic use.
L-Carnitine appears beside peptides in many research catalogs, but it is not a peptide. It is a small, naturally occurring amino-acid derivative whose identity, stereochemistry, chemical form and quantitative claim require their own controls. The live catalog offers 400mg, 600mg and 1200mg formats. This educational procurement guide explains how to compare those listings without giving instructions for biological, clinical or personal use.
Classify L-Carnitine before comparing suppliers
Define the requested material as L-carnitine, the biologically occurring L stereoisomer of carnitine, rather than calling it a peptide. A controlled specification should state the exact chemical name, CAS number where applicable, molecular formula and mass, stereochemical designation, chemical form, physical presentation, nominal quantity, intended Research Use Only scope and required documents. Generic terms such as carnitine, LC, amino acid or peptide catalog product are not sufficient identity controls. Require the quotation, sample, COA, label and invoice to use one consistent controlled name and SKU.
Resolve base, salt and solution differences
Current wholesale searches can refer to L-carnitine base, L-carnitine L-tartrate, other salts, bulk powder or a prepared solution. These are not automatically interchangeable because formula mass, assay basis, counterion contribution, water content and quantitative expression can differ. Ask the supplier to state the exact form and whether the reported amount represents L-carnitine equivalent, total salt, dry basis or as-is material. Record concentration and total volume separately for a solution. A buyer should reject a comparison that silently places a salt assay beside a base-content claim or treats total solution mass as active-material quantity.
Treat 400mg, 600mg and 1200mg as separate specifications
Create a distinct RFQ row for every format, including nominal amount per unit, unit count, total requested quantity, form, packaging, tolerance, parent lot, finished lot and price basis. A 1200mg unit is not documented merely by multiplying a 400mg label because filling records, containers, formulations and lot genealogy may differ. Ask which quantitative method or controlled fill record supports each claim and whether the stated amount excludes water, counterions and excipients. Compare cost only after the chemical form and amount basis have been normalized, and prohibit strength substitution without written approval.
Require stereoisomer and quantitative evidence on the COA
A useful batch COA should identify the exact L form, lot and specification and report a suitable identity result, assay or quantitative content, purity or related substances, water or loss on drying where relevant, and any stereochemical control required by the buyer. Because D-carnitine is a different stereoisomer, a generic purity percentage does not by itself demonstrate the requested stereochemical composition. Review the method reference, sample ID, acceptance criteria, actual results, test dates and authorization. HPLC area percentage, assay percentage and finished-unit content answer different questions and should remain separate fields.
Connect documents, labels and custody to the same batch
Request a signed batch COA, specification, SDS, storage statement and any additional composition or origin declaration needed for the transaction. Map the legal seller, manufacturer, testing laboratory, filler, release authority, inventory owner and shipper instead of assuming the trading company performs every role. Approve labels that show the complete material name, chemical form, strength, lot and RUO wording. At receiving, reconcile product, format, lot, quantity, packaging and documents. Quarantine unexplained form, stereochemistry, amount or certificate differences until the supplier provides a traceable correction.
Build one comparable wholesale RFQ matrix
Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.
Apply a batch-focused quality-control review
Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.
Create a documentation gate before dispatch
List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.
Verify supplier and batch ownership
Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.
Plan logistics and receiving controls
Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.
Use actual performance for repeat-order approval
A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.
Related products and same-category guides
- L-Carnitine 400mg
- L-Carnitine 600mg
- L-Carnitine 1200mg
- AICAR China Supplier Guide
- 5-Amino-1MQ Supplier Guide
Frequently asked questions
What should a batch-specific peptide COA include?
It should identify the exact material and lot, list specifications, methods and results, and connect clearly to applicable analytical evidence.
Does HPLC purity verify vial content?
No. Chromatographic purity and quantitative content are separate attributes and require suitable evidence.
Can similarly named peptides or blends be substituted?
No. A different identity, component ratio or strength requires technical review and explicit buyer approval.
Who confirms import requirements?
The importer or its broker must confirm current destination rules; supplier documents do not guarantee entry.
Request a wholesale research peptide quote
Send the exact product, strength, quantity, specification, destination, packaging and document requirements. Our B2B sourcing team will identify missing information before preparing a comparable quotation.
Request Wholesale Quote